跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
黃 彥鈞
副教授
,
大腸直腸外科
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北醫學大學癌症轉譯研究中心
https://orcid.org/0000-0002-5920-0053
電子郵件
d622101001
tmu.edu
tw
h-index
650
引文
15
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2025
每年研究成果
概覽
指紋
網路
專案
(4)
研究成果
(46)
資料集
(3)
類似的個人檔案
(6)
指紋
查看啟用 Yan-Jiun Huang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Colorectal Cancer
84%
Rectum Cancer
79%
Colon Cancer
59%
Randomized Controlled Trial
49%
Laparoscopic Surgery
49%
Metastatic Carcinoma
48%
Meta-Analysis
41%
Malignant Neoplasm
37%
Minimally Invasive Surgery
35%
Cancer Surgery
32%
Neoplasm
32%
Systematic Review
31%
Rectum Tumor
31%
Catenin
28%
Surgery
24%
Fluorouracil
24%
Matrilysin
24%
Carcinogenesis
23%
Radiation Therapy
20%
Open Surgery
20%
Network Meta-Analysis
20%
Colon
20%
Case-Control Study
20%
Salazosulfapyridine
20%
Cancer Associated Fibroblast
20%
Cancer
18%
Operation Duration
16%
Colony Formation
16%
Cancer Stem Cell
16%
Tumor Suppressor Protein
15%
Hemorrhoid
13%
In Vitro
13%
Chemoradiation Therapy
12%
Long Term Survival
12%
Chemoradiotherapy
11%
Da Vinci Surgical System
11%
Drug Resistance
11%
Chemosensitivity
10%
Cholangiocarcinoma
10%
Periampullary Cancer
10%
Sitagliptin
10%
Diabetes Mellitus
10%
Upregulation
10%
Learning Curve
10%
Feces Incontinence
10%
Cancer Cell
10%
Nodular Melanoma
10%
Proto Oncogene
10%
Segmentectomy
10%
Garcinia
10%
Biochemistry, Genetics and Molecular Biology
Colon
91%
Carcinogenesis
54%
Catenin
52%
Small Molecule
41%
Cancer Cell
36%
Cancer Stem Cell
34%
Fibroblast
24%
Mesenchymal-Epithelial Transition
23%
Upregulation
22%
Fluorouracil
19%
Tumor Suppressor Protein
17%
Side Population
16%
Drug Resistance
15%
Cluster of Differentiation
13%
Mechanistic Target of Rapamycin
13%
Docking (Molecular)
12%
STAT3
12%
Matrilysin
11%
down Regulation
11%
Computer Model
10%
Cell Cycle Progression
10%
SOX4
10%
CD24
10%
Antrodia camphorata
10%
Proto Oncogene
10%
AMPK Signaling
10%
Chemosensitivity
10%
Garcinia mangostana
10%
Folate Deficiency
10%
Tumor-Associated Macrophage
10%
Interleukin 8
10%
Folic Acid
10%
ATP Synthase
10%
Cyclin D1
10%
Binding Affinity
10%
YAP1
9%
Metalloprotease Inhibitor
8%
Interleukin 6
8%
Mouse
7%
Hypoxia Inducible Factor 1
7%
AMP-activated Protein Kinase
7%
Signal Transduction
7%
Western Blot
7%
Colony Formation
7%
Cell Cycle
6%
LGR5
6%
Vascular Endothelial Growth Factor
6%
Mouse Model
6%
Tumor Progression
5%
Cell Viability
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Colon Cancer
53%
Catenin
50%
Carcinogenesis
46%
Colorectal Cancer
39%
Neoplasm
27%
Postoperative Pain
18%
Tumor Microenvironment
16%
Fluorouracil
16%
Tumor Suppressor Protein
16%
Hemorrhoid
14%
Matrilysin
13%
Mammalian Target of Rapamycin
13%
Cardiovascular Disease
12%
microRNA 214
10%
Sulfasalazine
10%
Garcinia mangostana
10%
microRNA 200c
10%
Proton Pump Inhibitor
10%
Antrodia camphorata
10%
Sitagliptin
10%
Case-Control Study
10%
Colon Carcinogenesis
10%
Destruxin
10%
Repurposing
10%
Poly(n Isopropylacrylamide)
10%
Pancreas Cancer
10%
Antibody Conjugate
10%
Randomized Controlled Trial
10%
Folic Acid Deficiency
10%
Immunoassay
10%
Nanofiber
10%
Folic Acid
10%
Quantum Dot
10%
Diltiazem
10%
Breast Cancer
10%
Statin (Protein)
10%
Cardiotoxicity
10%
Drug Resistance
7%
Interleukin 6
7%
Metastasis Potential
6%
Tumor Growth
6%
Mouse Model
6%
Insulin-Like Growth Factor 1
6%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
6%
Trichostatin A
5%
Placebo
5%
Operative Blood Loss
5%
Postoperative Complication
5%
Recurrent Disease
5%
